Faculty Opinions recommendation of Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
2012 ◽
Vol 21
(18)
◽
pp. 3372-3380
◽
2007 ◽
Vol 35
(2)
◽
pp. 107-117
◽
2007 ◽
pp. 87-105
◽